Patient and health care system delays in the start of tuberculosis treatment in Norway

BMC Infectious Diseases
Mohamed Guled FarahGunnar A Bjune

Abstract

Delay in start of tuberculosis (TB) treatment has an impact at both the individual level, by increasing the risk of morbidity and mortality, and at the community level, by increasing the risk of transmission. The aims of this study were to assess the delays in the start of treatment for TB patients in Oslo/Akershus region, Norway and to analyze risk factors for the delays. This study was based on information from the National TB Registry, clinical case notes from hospitals and referral case notes from primary health care providers. Delays were divided into patient, health care system and total delays. The association with sex, birthplace, site of the disease and age group was analyzed by multiple linear regression. Among the 83 TB patients included in this study, 71 (86%) were born abroad. The median patient, health care system and total delays were 28, 33 and 63 days respectively, with a range of 1-434 days. In unadjusted analysis, patient delay and health care system delay did not vary significantly between men and women, according to birthplace or age group. Patients with extra-pulmonary TB had a significantly longer patient, health care system and total delay compared to patients with pulmonary TB. Median total delay was 81...Continue Reading

References

Dec 1, 1992·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·L Bonvin, J P Zellweger
Jan 1, 1991·Journal of Clinical Epidemiology·A C HauserP Balcke
Jun 1, 1989·Archives of Internal Medicine·S R CounsellR S Dittus
Mar 23, 1987·The American Journal of Medicine·S AlvarezS L Berk
Jun 1, 1987·Journal of the American Geriatrics Society·P R KatzJ Feather
Jun 1, 1985·Chest·I KatzD Michaeli
Mar 1, 1980·The American Review of Respiratory Disease·M GreenbaumP R Murray
Apr 1, 1982·The American Journal of Medicine·I D Bobrowitz
Sep 1, 1980·American Journal of Epidemiology·D A EnarsonE Dorken
Jan 1, 1995·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·T E Elkins, D Brown
Aug 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N BeyersP R Donald
Aug 1, 1994·Journal of Internal Medicine·A NaalsundJ Boe
Feb 14, 1994·Archives of Internal Medicine·P MathurF Gordin
Apr 1, 1993·Journal of Clinical Microbiology·R E HuebnerJ I Tokars
Jun 11, 1993·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Oct 16, 1996·JAMA : the Journal of the American Medical Association·A Pablos-MéndezT R Frieden
Oct 1, 1996·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J E PirkisA J Plant
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·K B Weiss, W W Addington
Mar 6, 1999·Annals of Internal Medicine·V K RaoM H Kollef
Apr 28, 2001·Journal of Clinical Microbiology·U R DahleD A Caugant
Sep 13, 2002·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·George A MensahWayne H Giles
Sep 26, 2002·BMC Public Health·Meaza DemissieYemane Berhane
Apr 26, 2003·BMJ : British Medical Journal·Alison RodgerHelen Maguire
Jul 5, 2003·Journal of Clinical Microbiology·Ulf R DahleDominique A Caugant
Aug 3, 2010·Infectious Disease Clinics of North America·Keertan DhedaMartin P Grobusch

❮ Previous
Next ❯

Citations

Sep 11, 2012·BMC Infectious Diseases·Isabella CoimbraRicardo Arraes de Alencar Ximenes
Jun 13, 2009·BMC Infectious Diseases·Chandrashekhar T SreeramareddyJ Van den Ende
Jan 16, 2008·BMC Public Health·Dag Gundersen StorlaGunnar Aksel Bjune
Jul 16, 2008·BMC Public Health·Jimmy P S ChernTzai-Hung Wen
Jan 9, 2009·BMC Public Health·Abdi A GeleFekadu Abebe
Feb 25, 2014·International Journal of Circumpolar Health·Vladimir N KuznetsovGunnar A Bjune
Oct 20, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J L ÁlvarezJ H Richardus
Sep 17, 2011·European Journal of Public Health·Anamarija Jurcev-Savicevic, Goran Kardum
Aug 21, 2013·Scandinavian Journal of Infectious Diseases·Kalbir S HayerAnnette L Wood
May 31, 2014·Tuberculosis Research and Treatment·Wei-Teng YangAmita Gupta
Jul 22, 2015·Revue de pneumologie clinique·E L P BembaE Aka Danguy
Aug 16, 2011·Tropical Medicine & International Health : TM & IH·Willem A LockSake J de Vlas
Oct 24, 2007·Tropical Medicine & International Health : TM & IH·Alexis CambanisLuis E Cuevas
Aug 12, 2015·BMC Infectious Diseases·Manju Raj PurohitCecilia Stålsby Lundborg
Jul 17, 2014·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Denise Rossato SilvaPaulo de Tarso Roth Dalcin
Jan 1, 2014·African Journal of Primary Health Care & Family Medicine·Valerie J Ehlers, Getahun S Aragaw
Aug 31, 2018·BMJ Case Reports·Savitha SubramaniRashmika Rajendran
Mar 30, 2010·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Mette SagbakkenGunnar A Bjune
Feb 9, 2020·Tropical Medicine & International Health : TM & IH·M MuniyandiK Rajendran
Nov 2, 2019·BMJ Open Respiratory Research·Poppy EvendenCharlotte S Anderson
Jan 14, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Dag Storla
Mar 2, 2013·Public Health Reports·Eyal OrenJonathan Mayer

❮ Previous
Next ❯

Methods Mentioned

BETA
x-ray

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.